MA50590A - Nouvelle immunothérapie dirigée contre plusieurs tumeurs du sang, en particulier la leucémie lymphoïde chronique (llc) - Google Patents

Nouvelle immunothérapie dirigée contre plusieurs tumeurs du sang, en particulier la leucémie lymphoïde chronique (llc)

Info

Publication number
MA50590A
MA50590A MA050590A MA50590A MA50590A MA 50590 A MA50590 A MA 50590A MA 050590 A MA050590 A MA 050590A MA 50590 A MA50590 A MA 50590A MA 50590 A MA50590 A MA 50590A
Authority
MA
Morocco
Prior art keywords
llc
lymphoid leukemia
especially chronic
chronic lymphoid
several blood
Prior art date
Application number
MA050590A
Other languages
English (en)
French (fr)
Inventor
Daniel Kowalewski
Hans-Georg Rammensee
Stefan Stevanovic
Juliane Stickel
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of MA50590A publication Critical patent/MA50590A/fr

Links

MA050590A 2014-06-20 2015-06-17 Nouvelle immunothérapie dirigée contre plusieurs tumeurs du sang, en particulier la leucémie lymphoïde chronique (llc) MA50590A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462014849P 2014-06-20 2014-06-20

Publications (1)

Publication Number Publication Date
MA50590A true MA50590A (fr) 2020-09-16

Family

ID=58699923

Family Applications (1)

Application Number Title Priority Date Filing Date
MA050590A MA50590A (fr) 2014-06-20 2015-06-17 Nouvelle immunothérapie dirigée contre plusieurs tumeurs du sang, en particulier la leucémie lymphoïde chronique (llc)

Country Status (2)

Country Link
AR (1) AR100926A1 (es)
MA (1) MA50590A (es)

Also Published As

Publication number Publication date
AR100926A1 (es) 2016-11-09

Similar Documents

Publication Publication Date Title
MA49280A (fr) Nouvelle immunothérapie contre plusieurs tumeurs du sang, tels que la leucémie myéloïde aiguë (aml)
DK3157549T3 (da) Hidtil ukendt immunterapi mod flere forskellige tumorer i blodet, navnlig kronisk lymfatisk leukæmi (CLL)
DK3183272T3 (da) Asymmetriske multispecifikke antistoffer
EP3224456A4 (en) Tapered cooling channel for airfoil
DK3126395T3 (da) Multispecifikke antistoffer
EP3131897B8 (en) Factor ixa inhibitors
EP3541375A4 (en) FACTOR XIIA INHIBITORS
EP3304917A4 (en) MUSIC STREAMING FOR SPORTING ACTIVITIES
EP3541381A4 (en) FACTOR XIIA INHIBITORS
BR112017001387A2 (pt) alargador.
EP3238468A4 (en) Locating services
BR112017001389A2 (pt) alargador.
EP3152043A4 (en) Conformable, removable film-based article
BR112017001388A2 (pt) alargador.
BR112017001386A2 (pt) alargador.
EP3131896A4 (en) Factor ixa inhibitors
EP3238717A4 (en) Cataplasm
EP3220081A4 (en) Semiconductor refrigerator
EP3198635A4 (en) Multi-chip self adjusting cooling solution
DK3109141T3 (da) Holder
EP3157553A4 (en) Treatment for chronic lymphocytic leukemia (cll)
FI20145367A (fi) Menetelmä katodikuparin tuottamiseksi
EP3265143A4 (en) Methods for adversely affecting biofilms
EP3229801A4 (en) Factor ixa inhibitors
DE112015001583A5 (de) Haltevorrichtung